Global Organ Function Assays Market, By Test Type (Immune Cell Function Assays, Liver Function Assay, Kidney Function Assay, Integrated Organ Function Assay), End Use (Hospitals, Outpatient Clinics, Diagnostics Laboratories, Academic and Research Institutes, Home Care) – Industry Trends and Forecast to 2029.
Organ Function Assays Market Analysis and Size
Organ function assays are also created to gauge medication levels in the body and determine whether a substance is specifically poisonous to a given organ. Venipuncture blood collection is necessary for organ function assays, which are usually carried out in clinical laboratories utilizing specialized procedures and pricey equipment. The more invasive nature of traditional sample collection techniques results in a lengthier turnaround time for finishing a single test.
Data Bridge Market Research analyses that the organ function assays market which is expected to undergo a CAGR of 8.00% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Organ Function Assays Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Test Type (Immune Cell Function Assays, Liver Function Assay, Kidney Function Assay, Integrated Organ Function Assay), End Use (Hospitals, Outpatient Clinics, Diagnostics Laboratories, Academic and Research Institutes, Home Care)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Cylex (U.S.), LXN Corporation (U.S.), Alpha Laboratories Ltd. (Canada), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Horiba Medical (France), Laboratory Corporation of America Holdings (U.S.), Randox Laboratories Ltd. (U.K.), Biobase Group (China), Otsuka Holdings Co., Ltd. (Japan)
|
|
Market Opportunities
|
|
Market Definition
Organ function assays are carried out more specifically to support a drug's efficacy and examine the organ function by determining the organ's marker concentration. Organ function prognostic marker testing offers a clear image of organ performance as well as a realistic estimate of a patient's physiological state.
Organ Function Assays Market Dynamics
Drivers
- Growth of point of care testing
A potential aid in the market's development is also becoming less effective due to the growth of point of care testing. The market for organ function assays will expand as a result of the numerous treatments and therapies attacking the essential organs, therefore, POC testing will be a key factor in this expansion.
- Inceasing in cases of liver cirrhosis
Increased liver cirrhosis cases and the emergence of illnesses brought by an unhealthy lifestyle have fuelled the prospective need for organ function assays in the global market. The organ transplantation industry is facing significant obstacles as a result of the rising incidence of kidney failure and end-stage renal disease. Due to the shortage of clinics assisting these healthcare facilities and the high morbidity and mortality ratio, the global market for organ function assays has shown phenomenal growth.
- Rise in chronic diseases
The high prevalence of chronic diseases and rising frequency of disorders linked to a sedentary lifestyle are the main drivers propelling the global organ function assays market. Additionally, the availability of appropriate reimbursement policies, particularly in developed economies, and the rise in organ transplant procedures in developed and some emerging nations are significant factors anticipated to support market expansion throughout the forecast period.
Opportunities
Growing organ transplantation rates and the incidence of lifestyle-related illnesses affecting the liver and kidneys have both contributed to the market's expansion over the past ten years. More trustworthy and efficient methods to monitor organ functions are required due to the rising number of patients with end-stage renal disease, liver cirrhosis, and other lethal illnesses, as well as the limited clinical effectiveness in reducing mortality from the forecast period. The reduction of the harm brought on by chronic illnesses depends critically on the early diagnosis of changes in organ function.
Restraints/Challenges
The cost of the facilities will impede the aforementioned growth drivers. The barriers in the predicted time period of 2022 to 2029 will be the slow-moving healthcare sector for organ transplantation and unsteady infrastructure in the sector of organ function assays.
This organ function assays market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the organ function assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Organ Function Assays Market
However, due to lockdowns and other restrictions imposed by the relevant governing bodies in response to the recent COVID-19 outbreak, the activities of several industries have either temporarily ceased or are operating with a small workforce. Similar to other markets, the global organ function assays market is expected to have significantly negative revenue growth as a result of this aspect. Over the course of this forecast period, the high expenses related to installing and maintaining these equipment may potentially restrain the global organ function assays market's revenue growth.
Global Organ Function Assays Market Scope
The organ function assays market is segmented on the basis of test type and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Immune Cell Function Assays
- Liver Function Assay
- Kidney Function Assay
- Integrated Organ Function Assay
End Use
- Hospitals
- Outpatient Clinics
- Diagnostics Laboratories
- Academic and Research Institutes
- Home Care
Organ Function Assays Market Regional Analysis/Insights
The organ function assays market is analysed and market size insights and trends are provided by country, test type and end use as referenced above.
The countries covered in the organ function assays market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the global organ function assays market in revenue terms owing to presence of proper medical infrastructure coupled with high prevalence of lifestyle related diseases in the region.
Asia-Pacific is expected to grow at the owing to presence of proper medical infrastructure coupled with high prevalence of lifestyle related diseases in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Organ Function Assays Market Share Analysis
The organ function assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to organ function assays market.
Some of the major players operating in the organ function assays market are:
- Cylex (U.S.)
- LXN Corporation (U.S.)
- Alpha Laboratories Ltd. (Canada)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Thermo Fisher Scientific Inc. (U.S.)
- Horiba Medical (France)
- Laboratory Corporation of America Holdings (U.S.)
- Randox Laboratories Ltd. (U.K.)
- Biobase Group (China)
- Otsuka Holdings Co., Ltd. (Japan)
SKU-